DK2831151T3 - Benzene polycarboxylic acid compounds and their use as a drug - Google Patents

Benzene polycarboxylic acid compounds and their use as a drug Download PDF

Info

Publication number
DK2831151T3
DK2831151T3 DK13728943.5T DK13728943T DK2831151T3 DK 2831151 T3 DK2831151 T3 DK 2831151T3 DK 13728943 T DK13728943 T DK 13728943T DK 2831151 T3 DK2831151 T3 DK 2831151T3
Authority
DK
Denmark
Prior art keywords
acid
compound
polycarboxylic acids
benzene polycarboxylic
treatment
Prior art date
Application number
DK13728943.5T
Other languages
Danish (da)
English (en)
Inventor
Valery Pavlovich Shipov
Evgeny Sergeevich Pigarev
Elena I Fedoros
Original Assignee
Rdinnovation Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rdinnovation Aps filed Critical Rdinnovation Aps
Application granted granted Critical
Publication of DK2831151T3 publication Critical patent/DK2831151T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G1/00—Low-molecular-weight derivatives of lignin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H6/00—Macromolecular compounds derived from lignin, e.g. tannins, humic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H8/00—Macromolecular compounds derived from lignocellulosic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK13728943.5T 2012-03-30 2013-04-02 Benzene polycarboxylic acid compounds and their use as a drug DK2831151T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261618037P 2012-03-30 2012-03-30
DKPA201270159 2012-03-30
PCT/DK2013/050092 WO2013143549A1 (en) 2012-03-30 2013-04-02 Benzene polycarboxylic acid compounds and their use as drug

Publications (1)

Publication Number Publication Date
DK2831151T3 true DK2831151T3 (en) 2017-03-06

Family

ID=49258251

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13728943.5T DK2831151T3 (en) 2012-03-30 2013-04-02 Benzene polycarboxylic acid compounds and their use as a drug

Country Status (22)

Country Link
US (1) US9644074B2 (enExample)
EP (1) EP2831151B1 (enExample)
JP (2) JP6190445B2 (enExample)
KR (1) KR101872452B1 (enExample)
CN (1) CN104245800B (enExample)
AR (1) AR090554A1 (enExample)
AU (1) AU2013242609C1 (enExample)
BR (1) BR112014023787B1 (enExample)
CA (1) CA2867758C (enExample)
DK (1) DK2831151T3 (enExample)
ES (1) ES2618938T3 (enExample)
HU (1) HUE032633T2 (enExample)
IL (1) IL234894A (enExample)
IN (1) IN2014DN09030A (enExample)
PL (1) PL2831151T3 (enExample)
PT (1) PT2831151T (enExample)
RU (1) RU2635562C2 (enExample)
SG (1) SG11201406163PA (enExample)
TW (1) TWI580433B (enExample)
UA (1) UA116535C2 (enExample)
WO (1) WO2013143549A1 (enExample)
ZA (1) ZA201407510B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7488903B2 (ja) * 2019-12-28 2024-05-22 中精普康（北京）医薬科技有限公司 結腸直腸癌又は腺腫を検出するためのバイオマーカー及びその方法
CN111205196B (zh) * 2020-03-04 2021-04-02 中国科学院昆明植物研究所 一种苯酚类ab环结构化合物及其制备方法和应用
KR20240070574A (ko) * 2021-09-13 2024-05-21 푼다시온 세네르 리그닌, 리그닌액 또는 흑액으로부터 항산화 조성물의 수득 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910873A (en) * 1974-05-30 1975-10-07 Westvaco Corp Production of water-soluble polycarboxylic lignin by an oxygen-alkali process
HU172831B (hu) * 1976-03-31 1978-12-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija kompleksov oligo- i poligalakturonnyk kislot s ionami zhiznenno vazhnykh metallov
JPS6041077B2 (ja) 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4657927A (en) 1978-05-04 1987-04-14 Research Corporation Malonato platinum compounds
JPS5948087A (ja) * 1982-05-11 1984-03-19 ジェネティクス・インタナショナル・インコーポレイテッド 生物学的に生産される酸沈澱性高分子リグニン
JPS6187610A (ja) * 1984-10-05 1986-05-06 Shiseido Co Ltd 化粧料
DE3707909A1 (de) * 1987-03-12 1988-09-22 Ruetgerswerke Ag Niedermolekulare alkalihuminate, verfahren zu ihrer herstellung und verwendung
NZ225271A (en) 1987-07-08 1991-02-26 Nat Energy Council Oxidising coal using a gaseous oxidant
DE3903773A1 (de) * 1988-02-11 1989-09-14 Nat Energy Council Eine mischung mit bakteriozider oder bakteriostatischer aktivitaet
GB2231564B (en) * 1989-05-15 1992-08-12 Nat Energy Council Seedling growth stimulation
DE4105247A1 (de) * 1990-02-28 1991-08-29 Nat Energy Council Pflanzliche spurenelement-verfuegbarkeit
DE4318210C2 (de) * 1993-06-01 1997-09-18 Chembico Chemisch Biolog Praep Verwendung von Huminstoffen als Lichtschutzmittel in der Biotechnologie und in der Landwirtschaft
US5688999A (en) * 1996-01-26 1997-11-18 Lignotech Usa, Inc. Production of oxidized humic acids by an oxygen-alkali process
JPH11206324A (ja) * 1998-01-22 1999-08-03 Morita Shokuzai Kaihatsu Kenkyusho:Kk アルコール及び抗菌剤の臭いと味質を改善する方法。
RU2172176C1 (ru) * 2000-06-19 2001-08-20 Общество с ограниченной ответственностью "Нобель" Способ получения противовирусного средства
RU2182482C1 (ru) * 2000-09-19 2002-05-20 РДИнновейшн Апс Способ получения противоопухолевого средства
RU2183124C1 (ru) * 2000-09-19 2002-06-10 РДИнновейшн Апс Способ получения радиопротектора
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
RU2205166C1 (ru) * 2001-12-19 2003-05-27 Общество с ограниченной ответственностью "Научно-производительное объединение "Реализация экологических технологий" Способ получения солей гуминовых кислот
ES2355818T7 (es) * 2002-12-12 2013-04-12 R.B.T. (Rakuto Bio Technologies) Ltd. Uso de lignina peroxidasa en el aclaramiento de la piel y el pelo
RU2350353C2 (ru) * 2005-02-17 2009-03-27 РДИнновейшн Апс Способ получения средства защиты организма от ионизирующего излучения
RU2368379C2 (ru) 2005-02-17 2009-09-27 РДИнновейшн Апс Способ получения антиракового средства
JP2006232785A (ja) * 2005-02-28 2006-09-07 Univ Of Tsukuba フルボ酸を用いるｉ型アレルギー抑制剤及びｉ型アレルギーの発症抑制方法。
WO2008064425A1 (en) * 2006-11-30 2008-06-05 Solbec Pharmaceuticals Limited Glycoalkaloid and chemotherapeutic agent combinations and various uses thereof
JP5224436B2 (ja) * 2007-07-26 2013-07-03 株式会社七沢研究所 清涼飲料水の製造方法
EP2025735A1 (en) * 2007-08-14 2009-02-18 Bergen Teknologioverforing AS One-step conversion of solid lignin to liquid products
FR2922452B1 (fr) 2007-10-19 2010-01-22 Coatex Sas Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations
JP2012503080A (ja) * 2008-09-19 2012-02-02 ザ プロクター アンド ギャンブル カンパニー 洗浄組成物で有用な変成リグニンバイオポリマー
CN102174202B (zh) * 2011-03-18 2014-04-02 华南理工大学 一种水溶性碱木质素羧酸盐及其制备方法
CN102241818B (zh) 2011-04-22 2013-06-19 宋玉军 一种聚羧酸系减水剂复配剂的制备方法

Also Published As

Publication number Publication date
KR20140143195A (ko) 2014-12-15
IN2014DN09030A (enExample) 2015-05-22
TW201402147A (zh) 2014-01-16
HUE032633T2 (en) 2017-10-30
BR112014023787A2 (enExample) 2017-06-20
AR090554A1 (es) 2014-11-19
EP2831151B1 (en) 2016-12-14
JP6190445B2 (ja) 2017-08-30
ES2618938T3 (es) 2017-06-22
SG11201406163PA (en) 2014-10-30
ZA201407510B (en) 2016-01-27
WO2013143549A1 (en) 2013-10-03
CN104245800A (zh) 2014-12-24
TWI580433B (zh) 2017-05-01
AU2013242609C1 (en) 2017-04-06
IL234894A (en) 2016-11-30
AU2013242609A1 (en) 2014-11-13
HK1205169A1 (en) 2015-12-11
PL2831151T3 (pl) 2017-06-30
PT2831151T (pt) 2017-03-17
CA2867758C (en) 2017-10-03
RU2014143650A (ru) 2016-05-27
US20160017104A1 (en) 2016-01-21
AU2013242609B2 (en) 2016-09-22
EP2831151A1 (en) 2015-02-04
CA2867758A1 (en) 2013-10-03
JP2015520121A (ja) 2015-07-16
CN104245800B (zh) 2017-09-08
UA116535C2 (uk) 2018-04-10
JP2017160447A (ja) 2017-09-14
KR101872452B1 (ko) 2018-06-28
BR112014023787B1 (pt) 2021-10-13
US9644074B2 (en) 2017-05-09
JP6730958B2 (ja) 2020-07-29
RU2635562C2 (ru) 2017-11-14

Similar Documents

Publication Publication Date Title
Wei et al. A mitochondria-localized oxygen self-sufficient two-photon nano-photosensitizer for ferroptosis-boosted photodynamic therapy under hypoxia
RU2742981C2 (ru) Комплексы металл-гликопротеин и их применение в качестве химиотерапевтических соединений
CA2816895C (en) Bismuth-containing compounds for modulating properties of biologically active agents
Bai et al. Superoxide dismutase-embedded metal–organic frameworks via biomimetic mineralization for the treatment of inflammatory bowel disease
AU2013242609C1 (en) Benzene polycarboxylic acid compounds and their use as drug
HK1205169B (en) Benzene polycarboxylic acid compounds and their use as drug
CN121021855B (zh) 基于TMPP配体的Pd-Zn异金属配位分子笼及抗肿瘤用途
JP2015520121A5 (enExample)
RU2102083C1 (ru) Способ получения противоопухолевого средства
WO2002024609A2 (en) Method for producing a radioprotector
SA113340430B1 (ar) مركبات حمض عديد كربوكسيليك بنزين جديدة
CN119191353A (zh) 一种MnZn-LDH-3MA层状双氢氧化物材料体系及其制备方法与应用
WO2024248769A1 (en) Nutritional support ingredients containing boron esters and their production method
CN117551008A (zh) 一种去铁胺偶联物及其制备方法和应用
US20130209582A1 (en) Hydrogen iodide-containing health food and hydrogen iodide-containing drug, and method for producing same
JP2008195613A (ja) マイクロ微粒子製剤および医薬組成物
CH514607A (de) Verfahren zur Herstellung von N2,N3-Dispirotripiperaziniumderivaten
Tamer et al. Improving Bio-Activity of Chitosan by Coupling with Phenolic Aldehyde: Characterization In Silico And Invitro Evaluation
CN1458156A (zh) 一类稀土配合物及其制备方法和在制备治疗肿瘤药物中的应用
WO1990003402A1 (fr) Nouveau compose, procede de preparation et son utilisation en medecine